z-logo
open-access-imgOpen Access
Endoscopic colorectal cancer surveillance in inflammatory bowel disease: Considerations that we must not forget
Author(s) -
Pauliúñez,
Rodrigo Quera,
David T. Rubin
Publication year - 2022
Publication title -
world journal of gastrointestinal endoscopy
Language(s) - English
Resource type - Journals
ISSN - 1948-5190
DOI - 10.4253/wjge.v14.i2.85
Subject(s) - medicine , inflammatory bowel disease , ulcerative colitis , colorectal cancer , disease , cancer , gastroenterology , rectum , crohn's disease , immune surveillance
Inflammatory bowel disease (IBD), encompassing Crohn's disease and ulcerative colitis, is a chronic immune-mediated inflammatory disease that primarily affects the gastrointestinal tract and is characterized by periods of activity and remission. The inflammatory activity of the disease involving the colon and rectum increases the risk of colorectal cancer (CRC) over the years. Although prevention strategies are evolving, regular surveillance for early detection of neoplasia as a secondary prevention strategy is paramount in the care of IBD patients. In this review article, we discuss the current evidence of the risks of developing CRC and evaluate the best available strategies for screening and surveillance, as well as future opportunities for cancer prevention.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here